EVGN — Evogene Ltd.
—
Nasdaq ·
Materials ·
Chemicals ·
CIK 1574565 ·
Last close
$0.71
Market Cap
$7.38M
52W High
$0.97
52W Low
$0.66
ADV30
56,079
Next earnings
2026-08-20
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 314,000 | -1,970,000 | -5,212,000 | -5,309,000 | 20,046,000 | 12,956,000 | 8,071,000 |
| Sep 2025 | 312,000 | 155,000 | -2,724,000 | 3,874,000 | 26,086,000 | 5,626,000 | 8,834,000 |
| Jun 2025 | 884,000 | 748,000 | -3,071,000 | -4,462,000 | 33,926,000 | 8,329,000 | 21,551,000 |
| Mar 2025 | 2,444,000 | 830,000 | -4,126,000 | -2,587,000 | 34,304,000 | 7,495,000 | 21,909,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,003,000
Investing CF
$-7,000
Financing CF
$-6,375,000
CapEx
$-136,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.17
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-282,556,000
Inventory
$210,000
Receivables
$1,378,000
ST Investments
$10,332,000
EBIT TTM
$-14,422,000
Pretax Income TTM
$-14,583,000
Interest Exp TTM
$161,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,844,000
EBITDA
$-13,495,000
Free Cash Flow
$-16,565,750
Enterprise Value
$11,343,935
Total Cash
$8,511,000
Total Debt
$2,031,000
Shares Out
10,412,764
Trailing EPS
$-1.70
Book Value
$-0.01
ROE
-171.8%
ROA
-33.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,853,000 | -14,034,000 | -8,485,000 | 20,046,000 | 8,071,000 | — | -13,502,000 |
| Dec 2024 | 5,577,000 | -18,804,000 | -16,485,000 | 39,864,000 | 25,026,000 | — | -19,700,000 |
| Dec 2023 | 2,982,000 | -22,231,000 | -23,879,000 | 51,101,000 | 22,416,000 | — | -21,577,000 |
| Dec 2022 | 1,675,000 | -26,941,000 | -26,638,000 | 56,126,000 | 21,336,000 | — | -23,678,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GWTI | GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES | $7.53M | $0.02 | — |
| PUBC | Purebase Corp | $7.02M | $0.02 | — |
| BON | Bon Natural Life Ltd | $7.79M | $1.28 | — |
| YCBD | cbdMD, Inc. | $7.98M | $0.76 | — |
| ORGN | Origin Materials, Inc. | $7.98M | $1.45 | — |
News headlines (Yahoo Finance, 1h cache)
Evogene Ltd. Q1 2026 Earnings Call Summary
2026-05-20 16:43 · Yahoo
Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN)
2026-05-20 13:59 · Yahoo
Evogene Reports First Quarter 2026 Financial Results
2026-05-20 11:00 · Yahoo
Evogene to Present at the 24th Schrödinger European User Group Meeting
2026-05-12 12:00 · Yahoo
Evogene Schedules First Quarter 2026 Financial Results Release
2026-05-07 12:00 · Yahoo
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
2026-04-02 20:01 · Yahoo
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
2026-03-31 12:00 · Yahoo
Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline
2026-03-14 01:01 · Yahoo
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
2026-03-09 13:00 · Yahoo
Evogene Ltd. Q4 2025 Earnings Call Summary
2026-03-06 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.